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Protein Production and Purification. 8ANC195, 8ANC195G52K5, 17b, PGT145, mG053, 2G12, 
CD4-Fc (domains 1 and 2 of human CD4 fused to human IgG1 Fc), human IgG1 Fc, and 
partially gl-reverted IgGs and/or Fabs were produced and purified as described in previous 
studies (Diskin et al., 2011; Scharf et al., 2014). Briefly, IgGs and Fabs were expressed by 
transient transfection in HEK293-6E cells with expression vectors containing the appropriate 
heavy and light chain genes. IgGs, CD4-Fc, and Fc were purified from cell supernatants using 
mAb Select Sure affinity chromatography (GE Healthcare). His-tagged Fabs were purified using 
Ni2+-NTA affinity chromatography (GE Healthcare) and Superdex 200 16/60 size exclusion 
chromatography (SEC) (GE Healthcare). 
 sCD4 (domains 1 and 2; residues 1-186 of mature CD4) was produced in baculovirus-
infected insect cells as described previously (Diskin et al., 2010; Scharf et al., 2014). 6x-His-
tagged protein was expressed in Hi5 cells, captured using Ni2+-NTA resin (GE Healthcare), and 
further purified using Superdex 200 16/60 SEC (GE Healthcare). 
 A gene encoding untagged BG505 SOSIP, a soluble gp140 trimer produced from HIV-1 
clade A strain BG505, was constructed as described (Sanders et al., 2013) to include the ‘SOS’ 
substitutions (A501Cgp120, T605Cgp41), the ‘IP’ substitution (I559Pgp41), the N-linked glycan site at 
residue 332gp120 (T332Ngp120); changing the gp120-gp41 cleavage site to 6R (REKR to 
RRRRRR), and introducing a stop codon after residue 664gp41 (Env numbering according to HX 
nomenclature). HEK293-6E cells treated with 5 µM kifunensine (Sigma) were co-transfected 
with plasmids encoding BG505 SOSIP and soluble furin at a ratio of 4:1. BG505 SOSIP protein 
was harvested from cell supernatants using a 2G12 immunoaffinity column made by covalently 
coupling 2G12 IgG monomer to an NHS-activated Sepharose column (GE Healthcare). After 
elution with 3M MgCl2 followed by immediate buffer exchange into Tris-buffered saline pH 8.0 
(TBS), trimers were purified using Superdex 200 16/60 SEC (GE Healthcare). The trimer 
fractions were pooled and re-purified using Superose 6 10/300 SEC (GE Healthcare). 
 
Crystallization 
Samples for crystallography were produced by incubating BG505 SOSIP with a 3-fold molar 
excess of sCD4 for 16 hrs at 4°C, followed by purification using Superdex 200 10/300 SEC (GE 
Healthcare). The resulting complex was incubated with a 3-fold molar excess of 8ANC195G52K5 
Fab and purified using Superose 6 10/300 SEC (GE Healthcare). Fractions corresponding to 
ternary complex were pooled and concentrated to a final OD of 14.0. Crystals of 8ANC195G52K5 
Fab–BG505 SOSIP complex (space group P21 a = 117.74 Å, b = 195.22 Å, c = 119.09 Å; β = 
101.6°; one molecule per asymmetric unit) were obtained by combining 0.2 µL of crystallization 
sample with 0.2 µL of 100 mM Tris pH 8.0, 15% PEG 3,350 and 2% 1,4-dioxane at 20°C. The 
crystals were cryoprotected in mother liquor solution supplemented with 25% ethylene glycol 
and plunge-frozen in liquid N2. 
 
Crystallographic Data Collection, Structure Determination, and Refinement 
X-ray diffraction data were collected at the Argonne National Laboratory Advanced Photon 
Source (APS) beamline 23-ID-D using a Pilatus3 6M detector. The data were indexed, 
integrated and scaled using XDS (Kabsch, 2010). The structure was solved by molecular 
replacement using a trimeric model of BG505 SOSIP derived from PDB 4TVP and 3 copies of 
8ANC195 Fab (PDB 4P9M). The model was refined to 3.58 Å resolution using an iterative 
approach involving (i) refinement applying NCS restraints and verification of model accuracy 
with simulated annealing composite omit maps using the Phenix crystallography package 
(Adams et al., 2010), and (ii) manually fitting models into electron density maps using Coot 
(Emsley and Cowtan, 2004). The final model (Rwork = 24.1%; Rfree = 28.6%) includes 21,288 
protein atoms and 1,016 carbohydrate atoms (Table S1). 96%, 4% and 0% of the residues were 
in the favored, allowed and disallowed regions, respectively, of the Ramachandran plot. 
Disordered residues that were not included in the model include residues 58-68, 134-150, 182-
191, 321-332, 399-413, 459-462 and 506-517 of gp120, residues 512-518 and 547-568 of gp41, 
and residues 129-134 and the 6x-His tag of the 8ANC195G52K5 HC. Solvent-exposed side chains 
not resolved in the electron density were stubbed. 
Buried surface areas were determined using PDBePISA (Krissinel and Henrick, 2007) 
and a 1.4 Å probe. The following distance and geometry criteria were used for assigning 
potential hydrogen bonds: a distance of < 3.5 Å, and a A-D-H angle of > 90˚. The maximum 
distance allowed for a van der Waals interaction was 4.0 Å. Hydrogen bond assignments should 
be considered tentative because of the relatively low resolution of the structure. Superimposition 
calculations were done and molecular representations were generated using PyMOL 
(Schrödinger, 2011) or UCSF Chimera (Pettersen et al., 2004). PDBeFold (Krissinel and 
Henrick, 2004) was used to perform pairwise Cα alignments. 
 
Surface Plasmon Resonance 
Experiments were performed using a Biacore T200 (Biacore). Protein A (Pierce) was primary 
amine-coupled on a CM5 chip (Biacore) at a coupling density of 12,000 resonance units (RUs). 
Capture proteins (PGT145 IgG, PGT121 IgG, CD4-Fc, 17b IgG, 21C IgG, or mG053 IgG) were 
injected over the chip at 100 nM concentration, followed by injection of 1 µM human Fc to block 
remaining protein A binding sites. mG053 does not bind BG505 SOSIP and was used to 
generate a reference flow cell. 500 nM BG505 SOSIP was subsequently injected, followed by a 
wash step with running buffer (HBS-EP+, GE Healthcare). 8ANC195, 8ANC195G52K5, and 
mutant/chimeric Fabs were injected over flow cells at increasing concentrations (1.95 to 1,000 
nM), at flow rates of 50 µl/min for 180 sec and allowed to dissociate for 600 sec. Flow cells were 
regenerated with 1 pulse each of 10 mM glycine pH 2.5 and 1 M guanidine HCl at a flow rate of 
90 µl/min. On/off rates (ka/kd) and binding constants (KD (M)) were calculated by kinetic analyses 
after subtraction of backgrounds using a 1:1 binding model with or without a bulk reflective index 
(RI) correction as appropriate (Biacore T200 Evaluation software).  
 
Neutralization Assays  
Neutralization of pseudoviruses derived from primary HIV-1 isolates was determined by 
observing the reduction of HIV-1 Tat-induced luciferase reporter gene expression in the 
presence of a single round of pseudovirus infection in TZM-bl cells as described (Montefiori, 
2005). Pseudoviruses were produced by cotransfection of HEK 293T cells with an Env 
expression plasmid and a replication-defective backbone plasmid. Pseudoviruses containing 
only high-mannose glycans were produced in HEK 293S (GnTI-/- cells). Neutralization assays 
were performed in-house for evaluating 8ANC195 mutants and YU2 gp41 glycosylation mutants 
(Table S3). Some of the data were generated with neutralization assays that were dispensed by 
a Freedom EVO® (Tecan) liquid handler (IC50 values derived from manual and robotic assays 
agreed to within 2-4 fold). In all cases, neutralization was monitored in the presence of a 4-fold 
Ab dilution series (each concentration run in duplicate or triplicate) after a single round of 
pseudovirus infection in the TZM-bl cell line (Montefiori, 2005). Nonlinear regression analysis 
was used to derive the concentrations at which half-maximal inhibition was observed (IC50 
values). 
 
Cryoelectron tomography 
Purified BG505 SOSIP-sCD4-17b-8ANC195G52K5 complexes were diluted to 60 µg/mL in TBS 
immediately before plunge freezing to avoid complex dissociation at low concentration. Sample 
grids were prepared by adding 3 µL of sample solution to a glow-discharged Quantifoil R2/2 
NH2 copper finder mesh with extra thick carbon grid (Quantifoil Micro Tools). After blotting for 
2.5 sec at 24°C and 95% humidity, grids were vitrified in liquid ethane using Mark IV Vitrobot 
(FEI Company). Frozen grids were transferred to a FEI Tecnai G2 Polara transmission electron 
microscope equipped with 300 keV FEG, a Gatan energy filter and a Gatan K2 Summit direct 
detector. Tilt series (±60°, 1° angular increments) were digitally recorded using the UCSF 
tomography software package (Zheng et al., 2007). Images were acquired under low dose 
conditions (120 e–/Å2 total for the tilt series at ~8 µm underfocus) at a nominal magnification of 
41,000x so that each pixel represented 2.6 Å. Tomographic reconstructions and CTF 
corrections were calculated using IMOD (Kremer et al., 1996). Individual tomograms were 
binned by 2 before alignment of particles and subtomogram averaging. Particles were picked 
using EMAN2.1 (Tang et al., 2007), and subtomogram averaging of 1745 subvolumes was 
performed using PEET (Nicastro et al., 2006) without using an external reference or applying C3 
symmetry. The resolution of the resulting map was estimated to be ~23 Å using a 0.143 gold-
standard Fourier shell correlation (FSC) calculated using IMOD (Kremer et al., 1996).  
 
Negative-stain single particle EM 
Purified BG505 SOSIP-sCD4-17b-8ANC195G52K5 complexes were diluted to 10 µg/mL in TBS 
immediately before adding 3 µL to a glow discharged ultrathin C film on holey carbon support 
film, 400 mesh, Cu grids (Ted Pella, Inc.). Samples on the grids were cross-linked using 
glutaraldehyde vapor and then stained with 3% uranyl acetate. Data were collected using a FEI 
Tecnai T12 transmission electron microscope operating at 120 keV equipped with a Gatan 
Ultrascan 2k X 2k CCD. Images were acquired using a 0.5 sec exposure time at a nominal 
magnification of 42,000x at 1 µm defocus, resulting in 2.5 Å per pixel. A total of 23,951 particles 
were picked using manual picking in EMAN2.1 (Tang et al., 2007) and automated picking in 
RELION (Scheres, 2012), and the CTF correction was done using EMAN2.1 (Tang et al., 2007). 
Initial reference-free 2D class averaging was performed using RELION and all particles were 
sorted into 480 classes. 14,096 particles corresponding to good class averages were selected, 
and the particles were further sorted using 3D classification in RELION. Refinement was 
conducted using 80 Å low-pass filtered structures calculated from models of 8ANC195-sCD4-
17b docked onto gp120 cores of partially-open (PDB 3DNL), open (PDB 3DNO), and closed 
(PDB 3DNN) trimer and 7,174 particles with C3 symmetry applied. We used the model from 
from the partially-open complex for the final structure, but results were similar when using the 
starting model for the open complex (Figure S5) or when using references calculated from 
model complexes without either sCD4 or 17b (data not shown). The resolution of the final 
reconstruction was ~17 Å calculated with RELION (Scheres, 2012) using a gold-standard FSC 
and a 0.143 cutoff as recommended for resolution estimations for single particle EM 
reconstructions (Scheres and Chen, 2012).  
 
Fitting of EM density maps 
EM structures were visualized using IMOD and USCF Chimera (Kremer et al., 1996; Pettersen 
et al., 2004). Coordinates from crystal structures were fit into the sub-tomogram averaged or 
negative stain single particle EM structures using the fit in map utility within UCSF Chimera 
(Pettersen et al., 2004) with the following options: real-time correlation/average update, and use 
map simulated from atoms, resolution 15 Å. The gp120-sCD4-17b complex structure (PDB 
1RZK) was first fit into EM density and then the 8ANC195 Fab (PDB 4P9M) was independently 
fit to remaining density. For comparisons with open (PDB 3DNO), partially-open (PDB 3DNL), 
and closed (PDB 3DNN) Env trimer structures, the coordinates for YU2 gp120 in the fitted 
complexes were replaced by coordinates for HXBc2 gp120, the strain used for those structure 
determinations.  
Table S1. Data collection and refinement statistics, molecular replacement, Related to 
Figure 1. 
 
 
 
8ANC195G52K5 Fab/BG505 SOSIP.664 complex 
Data collection 
 Resolution range (Å) 29.73  - 3.58 (3.711  - 3.58) 
Space group P21 
Cell dimensions 
!     a, b, c (Å) 117.73, 195.22, 119.09 
     α, β, γ (°)! 90.0, 101.6, 90.0 
Total reflections 210397 (19046) 
Unique reflections 61171 (5654) 
Multiplicity 3.4 (3.4) 
Completeness (%) 99.0 (92.0) 
Mean I/σ(I) 12.96 (1.60) 
Wilson B-factor 130.24 
Rmerge 0.0776 (0.823) 
CC1/2 0.998 (0.525) 
CC* 1 (0.83) 
Refinement 
 Rwork/Rfree 0.241/!0.286 
Number of atoms 22304 
     Protein 21288 
     Ligands 1016 
Protein residues 2889 
RMS (bonds) 0.007 
RMS (angles) 0.87 
Clashscore 13.81 
Average B-factor 140.92 
     Protein 141.47 
     Ligands 129.42 
 
Statistics for the highest-resolution shell are shown in parentheses. 
 Table S3. In vitro Neutralization Data, Related to Figure 3.  
 
A. 
  IC50 (µg/mL) 
Antibody YU-2 BG505 
8ANC195  0.421 0.100 
8ANC195 LC T30A 0.446 0.059 
8ANC195 LC G30aA 0.300 0.052 
8ANC195 LC N31A  0.446 0.168 
8ANC195 LC W32A >50 >50 
8ANC195 LC Y49A 1.614 0.414 
8ANC195 LC G51A 0.455 0.122 
8ANC195 LC L54A 0.589 0.143 
8ANC195 LC Y91A 2.639 1.340 
8ANC195 LC D92A 0.628 0.102 
8ANC195 LC T93A 0.446 0.059 
8ANC195 LC Y96A 0.300 0.052 
8ANC195 HC D99A 0.565 0.139 
8ANC195 HC K100A 0.310 0.190 
8ANC195 HC W100aA 1.067 0.141 
8ANC195 HC G100cA 0.407 0.154 
8ANC195 HC H100eA 0.424 0.354 
8ANC195 HC H100fA 0.415 0.304 
8ANC195 HC D100gA 0.312 0.119 
 
B. 
 IC50 (µg/mL) 
Antibody YU2              
high mannose 
glycans 
YU2 
high mannose + 
complex glycans 
PVO                
high mannose 
glycans 
PVO 
high mannose + 
complex glycans 
8ANC195 1.04 0.52 0.35 0.57 
8ANC195G52K5  0.59 0.33 0.23 0.28 
3BNC60  0.005 0.03 0.01 0.11 
PG16 0.15 0.31* 4.7 13.0* 
PGT121 0.07 0.06 0.26 0.14 
*maximum neutralization only reached 80% 
 
Table S3. In vitro Neutralization Data. (A) Neutralization of YU2 and BG505 pseudoviruses by 
8ANC195 mutants. (B) Neutralization of YU2 and PVO containing only high-mannose N-glycans 
or mixtures of N-glycans by 8ANC195-related bNAbs and control bNAbs. Consistent with 
previous reports that complex-type N-glycans partially protect the CD4 binding site (Binley et al., 
2010), 3BNC60 was more potent against high-mannose-only viruses. As also previously 
reported, the neutralization potency of PGT121 was unaffected (Mouquet et al., 2012).  
Table S4. Neutralization of YU2 PNGSgp41 mutants by 8ANC195 mutants and 
chimeras, Related to Figure 3. 
 
 IC50 (µg/mL) against YU2 
Antibody wt N611Q 
N625
Q 
N637
Q 
N611Q/ 
N637Q 
N625Q/ 
N637Q 
N611Q/ 
N625Q/ 
N637Q 
8ANC195 IgG 0.4 0.42 0.76 0.57 0.37 0.79 0.46 
8ANC195 mHC/glLC 7.53 17.11 ND 1.48 1.34 ND ND 
8ANC195 glCDRL1 55 >100 >100 3.42 1.80 17.40 6.64 
8ANC195 glCDRL2 6.26 13.6 54 3.48 0.71 3.91 0.72 
8ANC195 glCDRL3 0.79 ND ND ND 0.53 ND ND 
8ANC195 CDRL3Ala 38.6 ND >100 ND 2.77 28.8 5.66 
        
 IC50 fold change mutant virus/YU2 wt 
Antibody wt N611Q 
N625
Q 
N637
Q 
N611Q/ 
N637Q 
N625Q/ 
N637Q 
N611Q/ 
N625Q/ 
N637Q 
8ANC195 IgG 1 1.0 1.9 1.4 0.9 2.0 1.2 
8ANC195 mHC/glLC 19 2.3 ND 0.20 0.18 ND ND 
8ANC195 glCDRL1 138 >250 >250 0.06 0.03 0.32 0.12 
8ANC195 glCDRL2 16 2.2 8.6 0.56 0.11 0.63 0.12 
8ANC195 glCDRL3 2.0 ND ND ND 0.67 ND ND 
8ANC195 CDRL3Ala 97 ND >250 ND 0.07 0.74 0.15 
        
 IC50 fold change mutant antibody/8ANC195 wt 
Antibody wt N611Q 
N625
Q 
N637
Q 
N611Q/ 
N637Q 
N625Q/ 
N637Q 
N611Q/ 
N625Q/ 
N637Q 
8ANC195 IgG 1 1 1 1 1 1 1 
8ANC195 mHC/glLC 19 41 ND 2.6 3.6 ND ND 
8ANC195 glCDRL1 138 >1000 >1000 6.0 4.8 22 14 
8ANC195 glCDRL2 16 33 71 6.0 1.9 5.0 1.6 
8ANC195 glCDRL3 2.0 ND ND ND 1.4 ND ND 
8ANC195 CDRL3Ala 97 ND >1000 ND 7.4 37 12 
        
color scale (IC50; µg/mL) 0.1 - 1 1.1 - 5 5.1 - 20 > 20  
      
color scale (fold-change) <0.05 0.051 - 0.2 0.21 - 4.9 5 - 20 > 20 
 
Table S5: Distance comparisons in Env trimer structures, Related to Figure 6. 
Trimer&
conformational&
state&
&
Ligand&
&
+/4&
sCD4&
&
Trimer&type&
&
Method&
&
EMDB/PBD&
ID&
&
Resolution&
(Å)&
Distance&between&
CD4bs&(D368)&(Å)&
closed' 8ANC195G52K5' 2' BG505'SOSIP.664' crystal'structure' this'study' 3.58''' 54'
closed' PGT122,'35O22' 2' BG505'SOSIP.664' crystal'structure' 4TVP' 3.5' 55'
closed' PGT122' 2' BG505'SOSIP.664' crystal'structure' 4NCO' 4.7' 56'
closed' PG04'' 2' BG505'SOSIP.664' single'particle'cryo2EM' 3J5M' 5.8' 53'
closed' VRC03' 2' KNH1144'SOSIP.681' single'particle'cryo2EM' 4CC8' 6' 57'
closed' VRC01' 2' JRFL'SOSIP.681' single'particle'NS'EM' 6194' 20' 55'
closed' no'ligand' 2' BaL'virion' cryo2ET,'sub2tomogram'ave' 3DNN' 20' 63'
closed' VRC01' 2' BG505'SOSIP.664' single'particle'NS'EM' 6252' 22' 61'
closed' VRC01' '' BaL'virion' cryo2ET,'sub2tomogram'ave' 5457' 24' 68'
'' '' '' '' '' '' '' 55&±&5&
partially'open' A12' 2' BaL'virion' cryo2ET,'sub2tomogram'ave' 5544' N/A' 75'
partially'open' b12' 2' BaL'virion' cryo2ET,'sub2tomogram'ave' 3DNL' 20' 76'
'' '' '' '' '' '' '' 75&±&1&
partially'open*' 8ANC195G52K5,'
sCD4,'17b'
+' BG505'SOSIP.664' single'particle'NS'EM' this'study' 17' 79'
partially'open*' 8ANC195G52K5,'
sCD4,'17b'
+' BG505'SOSIP.664' cryo2ET,'sub2tomogram'ave' this'study' 23' 82'
'' '' '' '' '' '' '' 80&±&2&
open' sCD4' +' JR2FL'SOSIP.681' cryo2ET,'sub2tomogram'ave' 5322' 20' 94'
open' sCD4' +' KNH1144'SOSIP.681' cryo2ET,'sub2tomogram'ave' 5321' 20' 94'
open' sCD4' +' BaL'virion' cryo2ET,'sub2tomogram'ave' 5455' 24' 82'
open' sCD4,'17b' +' BaL'virion' cryo2ET,'sub2tomogram'ave' 3DNO' 20' 87'
open' sCD4,'17b' +' KNH1144'SOSIP.681' cryo2ET,'sub2tomogram'ave' 5323' 20' 87'
open' sCD4,'17b' +' JR2FL'SOSIP.681' cryo2ET,'sub2tomogram'ave' 5324' 20' 90'
open' sCD4,'17b' +' BG505'SOSIP.664' single'particle'NS'EM' 5723' 22' 85'
open' 17b' 2' KNH1144'SOSIP.681' single'particle'cryo2EM' 5462*' 8.8' 88'
open' 17b' 2' KNH1144'SOSIP.681' cryo2ET,'sub2tomogram'ave' 5325' 20' 85'
open' 17b' 2' BaL'virion' cryo2ET,'sub2tomogram'ave' 5456' 22' 85'
open' 17b,'VRC01' 2' BaL'virion' cryo2ET,'sub2tomogram'ave' 5461' 28' 88'
open' Z13e1' 2' KNH1144'SOSIP.681' single'particle'cryo2EM'' 5680' 18.5' 83'
' ' ' ' ' ' '
87&±&4&
Table S5: Distance comparisons in Env trimer structures, related to Figure 5. Structures 
are grouped into four conformational states: closed (unliganded and bound to Fabs), partially 
open (bound to A12 or b12), partially open* (bound to 8ANC195, sCD4, 17b; this study), and 
open (bound to sCD4 and/or 17b, or Z13e1). The EMDB or PDB identifier is given for each 
structure. When available, PDB coordinates for gp120 subunits within a trimer were used to 
measure the distances between CD4 binding site residue Asp368gp120 on adjacent protomers 
(PDB coordinates for EMDB entry 5462, marked with an asterisk, were obtained from Sriram 
Subramaniam). When PDB coordinates were not available, gp120s were fit to density maps in 
the EMDB using UCSF Chimera (Pettersen et al., 2004). The mean and standard deviation for 
distances are listed for each category of trimer structure. 
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